Caglayan Geredeli
Istinye, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 65 publications
Romiplostim versus Placebo for Chemotherapy-Induced Thrombocytopenia.
Journal: The New England journal of medicine
Published: March 11, 2026
The Impact of Concurrent Proton Pump Inhibitors on Nivolumab Response in Metastatic Non-Small Cell Lung Cancer: A Multicenter Real-Life Study.
Journal: Medicina (Kaunas, Lithuania)
Published: November 24, 2025
Second-line nab-paclitaxel and gemcitabine for advanced pancreatic cancer following FOLFIRINOX: outcomes and insights.
Journal: American journal of cancer research
Published: October 01, 2025
Superiority of Pathologic Lymph Node Ratio over Positive Lymph Node Count in Operated Early-Stage Breast Cancer.
Journal: Annali italiani di chirurgia
Published: December 26, 2024
Sequential Use of Sorafenib and Regorafenib in Hepatocellular Cancer Recurrence After Liver Transplantation: Treatment Strategies and Outcomes.
Journal: Cancers
Published: October 24, 2024
The impact of body mass index on the progression-free survival of CDK 4/6 inhibitors in metastatic breast cancer patients.
Journal: Future oncology (London, England)
Published: September 24, 2024
Real-world treatment outcomes from nationwide Onco-colon Turkey registry in RAS wild-type patients treated with biologics second-line mCRC.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: April 13, 2024
Clinicopathologic Features and Efficacy of Induction Chemotherapy in Nasopharyngeal Carcinoma: Real-World Experience.
Journal: Oncology research and treatment
Published: October 23, 2023
The XRCC1 and TP53 gene polymorphisms are associated with advanced-stage disease and early distant metastasis at diagnosis in non-small cell lung cancer.
Journal: Journal of cancer research and therapeutics
Published: October 03, 2023
The Prognostic Role of Mismatch Repair Status and CDX-2 Expression with Inflammatory Markers and Pathological Risk Factors in Stage II and III Colon Cancer: Multicenter Real-Life Data.
Journal: Journal of gastrointestinal cancer
Published: June 09, 2023
The effect of concomitant proton pump inhibitor use on survival outcomes of Nivolumab-treated renal cell carcinoma patients: a multicenter study.
Journal: Journal of cancer research and clinical oncology
Published: April 07, 2023
Last Updated: 09/26/2026